The role of lifestyle changes in the management of chronic liver disease

The prevalence of obesity worldwide has dramatically increased during the last three decades. With obesity comes a variety of adverse health outcomes which are grouped under the umbrella of metabolic syndrome. The liver in particular seems to be significantly impacted by fat deposition in the presence of obesity. In this article we discuss several liver conditions which are directly affected by overweight and obese status, including non-alcoholic fatty liver disease, chronic infection with hepatitis C virus and post-liver transplant status. The deleterious effects of obesity on liver disease and overall health can be significantly impacted by a culture that fosters sustained nutritional improvement and regular physical activity. Here we summarize the current evidence supporting non-pharmacological, lifestyle interventions that lead to weight reduction, improved physical activity and better nutrition as part of the management and treatment of these liver conditions.

[1]  F. Schaffner,et al.  Effect of weight reduction on hepatic abnormalities in overweight patients. , 1990, Gastroenterology.

[2]  F. Pattou,et al.  Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. , 2009, Gastroenterology.

[3]  F. Brunetti,et al.  Liver Involvement in Obese Children (Ultrasonography and Liver Enzyme Levels at Diagnosis and During Follow-up in an Italian Population) , 1997, Digestive Diseases and Sciences.

[4]  Jin Hwa Kang,et al.  The Relation Between Non-Alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease in Koreans , 2009, The American Journal of Gastroenterology.

[5]  R. Andrade,et al.  Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. , 2005, Gastroenterology.

[6]  M. Szklo,et al.  Prevalence of Type 2 Diabetes Mellitus among Persons with Hepatitis C Virus Infection in the United States , 2000, Annals of Internal Medicine.

[7]  R. Wiesner,et al.  Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. , 2000, Journal of hepatology.

[8]  E. Keeffe,et al.  Diabetes Mellitus Increases the Risk of Mortality Following Liver Transplantation Independent of MELD Score , 2010, Digestive Diseases and Sciences.

[9]  A. Feldstein,et al.  Clinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infection. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  M. Raponi,et al.  Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention. , 2009, World journal of gastroenterology.

[11]  H. Conjeevaram,et al.  One-Year Intense Nutritional Counseling Results in Histological Improvement in Patients with Nonalcoholic Steatohepatitis: A Pilot Study , 2005, The American Journal of Gastroenterology.

[12]  D. Purdie,et al.  Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life , 2004, Gut.

[13]  D. Purdie,et al.  In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. , 2003, Journal of hepatology.

[14]  A. Sanyal,et al.  Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. , 2004, Clinics in liver disease.

[15]  M. Gambardella,et al.  Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity , 2001, Hepatology.

[16]  S. Nair,et al.  Effects of obesity, diabetes, and prior abdominal surgery on resource utilization in liver transplantation: A single‐center study , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  J. Takeda,et al.  Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. , 2007, World journal of gastroenterology.

[18]  E. Jackvony,et al.  Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis , 2010, Hepatology.

[19]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[20]  A. McCullough,et al.  Posttransplant metabolic syndrome: An epidemic waiting to happen , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[21]  A. Lok,et al.  Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial. , 2009, Gastroenterology.

[22]  Jeffrey B. Schwimmer,et al.  Prevalence of Fatty Liver in Children and Adolescents , 2006, Pediatrics.

[23]  F. Negro,et al.  Pioglitazone in chronic hepatitis C not responding to pegylated interferon-alpha and ribavirin. , 2008, Journal of hepatology.

[24]  H. Cotrim,et al.  Nonalcoholic fatty liver disease in severely obese individuals: the influence of bariatric surgery. , 2008, Annals of hepatology.

[25]  J. George,et al.  Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss , 2009, Hepatology.

[26]  K. Tanikawa,et al.  Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. , 1997, Journal of hepatology.

[27]  M. L. de la Mata,et al.  Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa‐2a plus ribavirin , 2009, Hepatology.

[28]  T. Lehtimäki,et al.  Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance. , 2009, The Journal of clinical endocrinology and metabolism.

[29]  F. Brancati,et al.  Insulin resistance syndrome and nonalcoholic fatty liver disease. , 2003, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[30]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[31]  G. Tomlinson,et al.  High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. , 2001, Hepatology.

[32]  M. Carbone,et al.  196 HIGH PREVALENCE OF METABOLIC SYNDROME AND LONG-TERM SURVIVAL AFTER LIVER TRANSPLANTATION , 2008 .

[33]  M. Manco,et al.  Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial , 2008, Hepatology.

[34]  G. Marchesini,et al.  Metabolic syndrome in liver transplantation: Relation to etiology and immunosuppression , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[35]  M. Bondi,et al.  Hepatic steatosis in obese patients: clinical aspects and prognostic significance , 2004, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[36]  Hirokazu Takahashi,et al.  A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff , 2009, Journal of Gastroenterology.

[37]  M. Laryea,et al.  Metabolic syndrome in liver transplant recipients: Prevalence and association with major vascular events , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[38]  A. Bauman,et al.  Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors , 2009, Journal of gastroenterology and hepatology.

[39]  Z. Younossi,et al.  Nutritional Assessments of Patients with Non-alcoholic Fatty Liver Disease , 2010, Obesity surgery.

[40]  D. Purdie,et al.  Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C , 2002, Gut.